Diversity is not the same as equity in US cannabis industry
Commentary argues that repair must follow harm and power must include the people who built the road to legalization.
Read the evidence-backed report →VeedAtlas Research Desk
Global cannabis market updates connected to the brands, products, regulators, and countries people search for.
Commentary argues that repair must follow harm and power must include the people who built the road to legalization.
Read the evidence-backed report →The gap stems from the state's THC potency tax, which is scheduled to end on Oct. 1.
Read the evidence-backed report →Combined medical and adult-use purchases through July 11 put the state on track to surpass its previous yearly sales high.
Read the evidence-backed report →A new regulatory pathway could let existing adult-use stores register with the DEA and unlock federal tax benefits.
Read the evidence-backed report →German wholesaler Remexian distributed 7.6 tonnes of medical cannabis in Q2 2026, up 49% year-over-year, despite recent reimbursement changes for flower.
Read the evidence-backed report →Vertanical's Exilby oral extract debuts weeks after dried cannabis flowers lost national health reimbursement, giving the new pharmaceutical a regulatory edge but raising patient access concerns.
Read the evidence-backed report →The Canadian producer acquires Internod Pharma and HAP Pharma to secure direct import, distribution, and pharmacy capabilities in the UK medical cannabis market.
Read the evidence-backed report →Curaleaf has formally launched its unsolicited bid for Aurora Cannabis, setting a December 1 deadline while Aurora urges shareholders to take no action.
Read the evidence-backed report →Dunbar Pharmaceuticals' WaterClear THC range brings plant-derived dronabinol capsules, oral spray, and dropper solution to UK clinicians via IPS Pharma.
Read the evidence-backed report →Private unlicensed cannabis dispensing in England grew 154% year-on-year, while imports of flower and THC extracts surged ahead of a landmark regulatory review.
Read the evidence-backed report →A US$236 million hostile offer would combine two of the continent's largest medical cannabis operators, but Aurora's board is not yet convinced.
Read the evidence-backed report →Smoking ties the pollster's record high while edibles show a gender gap, with women outpacing men.
Read the evidence-backed report →A University of Georgia analysis of more than 20 million survey responses finds fewer sick days in states with medical cannabis laws, with the strongest effect in physically demanding jobs.
Read the evidence-backed report →The university claims the Colorado cannabis terpenes brand's name and red-and-white script logo are 'nearly identical' to its famous TERPS marks, while the company argues the trademark covers only athletic events and was canceled for years.
Read the evidence-backed report →The deal will rebrand eight Ponderosa Dispensary locations under JARS Cannabis and form a 27-store network across Arizona.
Read the evidence-backed report →The Illinois Department of Public Health expands patient access by approving two new debilitating conditions for the state's medical cannabis program.
Read the evidence-backed report →Shannon O’Brien alleges retaliation and privacy violations against Treasurer Deb Goldberg and the CCC.
Read the evidence-backed report →The Upper Peninsula operator suspends retail operations in five towns, blaming the state's wholesale cannabis tax for unsustainable costs.
Read the evidence-backed report →